Literature DB >> 16309576

Dehydroleucodine inhibits vascular smooth muscle cell proliferation in G2 phase.

M Cruzado1, C Castro, D Fernandez, L Gomez, M Roque, O E Giordano, L A Lopez.   

Abstract

Vascular smooth muscle cell (VSMC) proliferation plays an important role in the development of atherosclerosis and in the vascular changes seen in hypertension. Dehydroleucodine (DhL) is a sesquiterpene lactone that inhibits cell proliferation in plant cells. In this paper, we study the effect of DhL in the proliferation of VSMCs stimulated with 10% fetal bovine serum (FBS). Very low concentrations of DhL (2-6 microM) inhibited VSMC proliferation and induced cell accumulation in G2. DhL did not affect the dynamics of 3H-thymidine incorporation, and did not modify either the activity of DNA polymerase or the incorporation of deoxyribonucleotides in an in vitro assay. Moreover, DhL did not induce apoptosis in VSMCs. These results indicate that DhL, in very low concentration, induces a transient arrest of VSMCs in G2. Our data show that VSMCs are especially sensitive to DhL effect, suggesting that DhL could be potentially useful to prevent the vascular pathological changes seen in hypertension and other vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309576

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  2 in total

1.  Ethanolic Extracts of California Mugwort (Artemisia douglasiana Besser) Are Cytotoxic against Normal and Cancerous Human Cells.

Authors:  Himali Somaweera; Gary C Lai; Rachel Blackeye; Beverly Littlejohn; Justine Kirksey; Richard M Aguirre; Vince Lapena; Anna Pasqua; Mary McCarthy Hintz
Journal:  J Herb Med       Date:  2013-06-01       Impact factor: 3.032

2.  The sesquiterpene lactone dehydroleucodine triggers senescence and apoptosis in association with accumulation of DNA damage markers.

Authors:  Valeria V Costantino; Sabrina F Mansilla; Juliana Speroni; Celina Amaya; Darío Cuello-Carrión; Daniel R Ciocca; Horacio A Priestap; Manuel A Barbieri; Vanesa Gottifredi; Luis A Lopez
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.